NCT00514943 - BIBW 2992 (Afatinib) in Head & Neck Cancer | Biotech Hunter

Enrollment

124

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

March 31, 2010

Study Completion Date

July 31, 2013

Conditions

Head and Neck NeoplasmsCarcinoma, Squamous Cell

Interventions

DRUG

BIBW 2992

experimental drug taken once daily orally

DRUG

Cetuximab

active comparator administered weekly intravenously

Trial Locations (36)

Unknown

1200.28.0010 Boehringer Ingelheim Investigational Site, Stanford

1200.28.0001 Boehringer Ingelheim Investigational Site, Chicago

1200.28.0005 Boehringer Ingelheim Investigational Site, Chicago

1200.28.0011 Boehringer Ingelheim Investigational Site, Harvey

1200.28.0022 Boehringer Ingelheim Investigational Site, Indianapolis

1200.28.0024 Boehringer Ingelheim Investigational Site, Baltimore

1200.28.0012 Boehringer Ingelheim Investigational Site, Ann Arbor

1200.28.0021 Boehringer Ingelheim Investigational Site, Saint Joseph

1200.28.0016 Boehringer Ingelheim Investigational Site, Rochester

1200.28.0002 Boehringer Ingelheim Investigational Site, Jackson

1200.28.0006 Boehringer Ingelheim Investigational Site, Omaha

1200.28.0008 Boehringer Ingelheim Investigational Site, New Hyde Park

1200.28.0017 Boehringer Ingelheim Investigational Site, Chapel Hill

1200.28.0004 Boehringer Ingelheim Investigational Site, Winston-Salem

1200.28.0013 Boehringer Ingelheim Investigational Site, Charleston

1200.28.0007 Boehringer Ingelheim Investigational Site, Houston

1200.28.0009 Boehringer Ingelheim Investigational Site, Madison

1200.28.0020 Boehringer Ingelheim Investigational Site, Milwaukee

1200.28.0030 Boehringer Ingelheim Investigational Site, Brussels

1200.28.0031 Boehringer Ingelheim Investigational Site, Ghent

1200.28.0032 Boehringer Ingelheim Investigational Site, Leuven

1200.28.0062A Boehringer Ingelheim Investigational Site, Alès

1200.28.0062B Boehringer Ingelheim Investigational Site, Alès

1200.28.0059A Boehringer Ingelheim Investigational Site, Avignon

1200.28.0052A Boehringer Ingelheim Investigational Site, Lille

1200.28.0051A Boehringer Ingelheim Investigational Site, Lyon

1200.28.0050A Boehringer Ingelheim Investigational Site, Montpellier

1200.28.0058A Boehringer Ingelheim Investigational Site, Nîmes

1200.28.0061A Boehringer Ingelheim Investigational Site, Poitiers

1200.28.0055G Boehringer Ingelheim Investigational Site, Rouen

1200.28.0040 Boehringer Ingelheim Investigational Site, Barcelona

1200.28.0044 Boehringer Ingelheim Investigational Site, Barcelona

1200.28.0043 Boehringer Ingelheim Investigational Site, Madrid

1200.28.0042 Boehringer Ingelheim Investigational Site, Málaga

1200.28.0045 Boehringer Ingelheim Investigational Site, Santander

1200.28.0041 Boehringer Ingelheim Investigational Site, Valencia